STOCK TITAN

Bio-Key Intl (BKYI) Stock News

BKYI Nasdaq

Welcome to our dedicated page for Bio-Key Intl news (Ticker: BKYI), a resource for investors and traders seeking the latest updates and insights on Bio-Key Intl stock.

BIO-key International, Inc. reports developments in identity and access management software, biometric authentication technology, and related security hardware. The company’s updates center on cloud-hosted and on-premise PortalGuard IAM, biometric-centric multi-factor authentication, Passkey:YOU, and devices such as Pocket 10 Finger Scanners and Mobile POS Pro. Customer news includes software license renewals, public-sector channel partnerships, defense deployments, and retail-bank biometric identification programs.

Financial and corporate updates also cover operating results, revenue contributions from services, license fees, and hardware, Nasdaq listing compliance, periodic-report timing, and share-structure actions such as the company’s 1-for-10 reverse stock split.

Rhea-AI Summary

BIO-key International (Nasdaq: BKYI) and its strategic partner Visualforma have been awarded a new contract to enhance digital identity security for a Portuguese national security agency, extending their work from municipalities and public administration into one of Portugal’s most security-sensitive environments.

The deployment will use BIO-key’s PortalGuard IAM platform, WEB-key biometric authentication, Identity-Bound Biometrics (IBB), PIN:You PIN-based authentication, and EcoID III FBI PIV-certified fingerprint scanners to secure access to administrative systems, privileged accounts, and critical applications while meeting strict operational and cybersecurity requirements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

BIO-key (NASDAQ: BKYI) will host its Q2 2026 investor call and webcast on Friday, August 14th at 10 a.m. ET, led by Chairman & CEO Mike DePasquale and CFO Cecilia Welch. Investors can join via U.S. dial-in 1-877-418-5460, international 1-412-717-9594, or a live webcast with replay available for three months.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.26%
Tags
conferences
-
Rhea-AI Summary

BIO-key (Nasdaq: BKYI) announced a strategic partnership with Maktabi Tech, a regional technology firm focused on digital transformation and cybersecurity for the education sector in Saudi Arabia, Jordan, and the UAE. The collaboration will deliver BIO-key’s PortalGuard IAM platform, including Multi-Factor Authentication, Single Sign-On, passwordless authentication, and Identity-Bound Biometrics, to educational institutions across Saudi Arabia.

The partnership leverages Maktabi Tech’s established relationships and senior cybersecurity specialists to support identity modernization for schools, universities, and educational organizations. According to BIO-key, the agreement expands its presence in Saudi Arabia and aligns with the Kingdom’s Vision 2030 digital transformation and cybersecurity initiatives in education.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.49%
Tags
partnership
Rhea-AI Summary

BIO-key (Nasdaq: BKYI) announced that the Central Bank of Jordan (CBJ) has selected the company for a national biometric authentication initiative across Jordan’s financial sector, which serves about 11.6 million people. The project aims to shift end-client authentication toward a biometric-first model, reducing reliance on passwords, tokens and other legacy methods.

The CBJ is using BIO-key’s PortalGuard and WEB-key technologies to enable secure biometric authentication across digital and financial environments. BIO-key’s past contribution to a biometric banking deployment serving over 30 million customers and 850+ branches was highlighted. The scope, implementation framework and timeline for the Jordan initiative are still being developed between CBJ and BIO-key.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.53%
Tags
none
-
Rhea-AI Summary

BIO-key (Nasdaq: BKYI) announced that trading of its common stock will resume on the Nasdaq Capital Market at the market open on Wednesday, July 8, 2026. A Nasdaq Hearings Panel determined the company has regained compliance with continued listing standards, including minimum bid price and SEC filing requirements. BIO-key will be under a Discretionary Panel Monitor until July 6, 2027. Management highlights a growing base of recurring revenue, expanding interest in its biometric cybersecurity solutions, a solid financial position, and a streamlined cost structure, and expects significantly improved business results in 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
43.35%
Tags
none
-
Rhea-AI Summary

BIO-key (OTCQB: BKYI) will showcase its biometric-powered, passwordless identity and access management solutions at an invitation-only banking cybersecurity workshop in Amman, Jordan, on July 6. The Association of Banks in Jordan is hosting over 25 financial institutions, including C-level executives.

Sessions highlight BIO-key’s Identity-Bound Biometrics and PortalGuard IAM for secure, frictionless authentication, improved user experience, operational efficiency, regulatory compliance support, and cyber threat mitigation for regional banks undergoing digital transformation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.89%
Tags
none
Rhea-AI Summary

BIO-key (OTC:BKYI) CEO Michael DePasquale will join a webcast fireside chat at Maxim Group’s Defense Tech Virtual Conference on Thursday, June 25, 2026 at 4:00 p.m. ET (Track 2). Investors can register online to attend the virtual event.

DePasquale plans to discuss BIO-key’s biometric authentication solutions for military, defense and other high-value sectors, and provide an outlook including anticipated 50% 1H 2026 revenue growth to about $5M and a shift to profitability compared with a $(1.9M) loss in 1H 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.31%
Tags
conferences
-
Rhea-AI Summary

BIO-key (OTC Markets: BKYI) received a Nasdaq notice of non-compliance with Listing Rule 5250(c)(1) because it did not timely file its Form 10-Q for the quarter ended March 31, 2026.

A Nasdaq Hearing Panel will consider this issue when deciding BIO-key’s continued listing on the Nasdaq Capital Market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.81%
Tags
none
-
Rhea-AI Summary

BIO-key (OTC:BKYI) will present at the RedChip Future Tech Investor Conference on Wednesday, June 10, 2026 at 3:00 pm ET, followed by a live Q&A.

The company expects 1H 2026 revenue of about $5M, up from $3.3M, and to reach 1H profitability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.61%
Tags
none
Rhea-AI Summary

BIO-key (OTC:BKYI) announced a strategic partnership with IT solutions provider BlueAlly, highlighted by deployment of its PortalGuard platform at AOD Federal Credit Union in Alabama.

The rollout delivers phishing-resistant, identity-bound biometric authentication to reduce MFA-related risks, streamline operations, lower help desk demand, and support zero-trust security and regulatory compliance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.67%
Tags
none

FAQ

What is the current stock price of Bio-Key Intl (BKYI)?

The current stock price of Bio-Key Intl (BKYI) is $4.17 as of August 10, 2026.

What is the market cap of Bio-Key Intl (BKYI)?

The market cap of Bio-Key Intl (BKYI) is approximately 4.4M.